[Issuer Free Writing Prospectus Registration Statement No. 333-230768 (Supplementing Preliminary Prospectus Supplement On April 10, 2019, at certain investor presentations, a representative of the Company indicated that there was a 60-70% probability that the Company may engage in an acquisition of a]
[China Bat Group, Inc. Provides Notice of Proposed Settlement of Derivative Litigation Company Stipulation Kodali v. Qin, et al., Derivative Litigation BEIJING, April 12, 2019 /GLOBE NEWSWIRE/ -- China Bat Group, Inc. (Nasdaq: GLG) (the “ On April 4, 2019, the Court issued an order preliminary approv]
[TABLE OF C INTRODUCTION 1 1 PART I. 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 40 ITEM 4A UNRESOLVED STAFF COMMENTS 70 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROS]
[Table of Contents SEMILEDS CORPORATION FORM 10-Q for the Quarter Ended February 28, 2018 Page No. Part I. Financial Information Item 1. Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets as of February 28, 2019 and August 31, 2018 1 Unaudited Condensed Consolidated Statements of ]
[PROSPECTUS SUPPLEMENT (To Prospectus dated April 10, 2019) File No. 333-230686 CHINA JO-JO DRUGSTORES, INC. 4,000,008 Shares of Common Stock Our common stock trades on the Nasdaq Capital Market under the symbol “CJJD.” The last reported sale price of our common stock on the Nasdaq Capital Market on ]
[SCHEDULE 13D CUSIP No. 26853A100 1 NAME OF REPORTING PERSON The Baring Asia Private Equity Fund VI, L.P.1 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☒]
[China Life Insurance Company Limited Annual Report 2018 Contents Prelude 3 Chairmans Statement 15 Management Discussion and Analysis 21 Embedded Value 46 Significant Events 54 Corporate Governance 74 Other Information 144 Financial Report 151 1 2 China Life Insurance Company Limited Annual Report 2]
